サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467630

遺伝子発現解析市場レポート：製品・サービス、技術、生産能力、エンドユーザー、地域別、2024～2032年

Gene Expression Analysis Market Report by Products & Services, Technology (Polymerase Chain Reaction, Next Generation Sequencing, DNA Microarray, Sanger Sequencing, and Others), Capacity, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 136 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
遺伝子発現解析市場レポート：製品・サービス、技術、生産能力、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子発現解析市場規模は2023年に51億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに110億米ドルに達し、2024～2032年の間に8.6％の成長率（CAGR）を示すと予測しています。

遺伝子発現解析（GEA）は、生物学的システムの挙動を調査するために遺伝子からデータを抽出する方法です。遺伝子発現解析には、遺伝子の転写、翻訳、タンパク質の翻訳後修飾、RNAスプライシングなどのさまざまなプロセスが含まれます。この分析から得られたデータは、タンパク質、リボ核酸（RNA）、様々な微生物学的産物の生産に利用されます。さらに、新薬の開発や既存の診断法の改良にも活用されています。GEAは現在、薬理ゲノミクス、バイオマーキング、毒物学、診断学に幅広く応用されており、多くの医療的疾患の原因メカニズムを説明する上で不可欠であると広く考えられています。

個別化医療に対する需要の高まりとともに、標的分子治療の採用が増加していることも、市場の成長を促す主要要因の一つです。GEAは分子生物学的研究において強力なツールであることが証明されており、遺伝子の機能を理解し、病気を診断し、医薬品開発を促進するために使用されています。さらに、がん、結核、心血管疾患、遺伝性疾患などの慢性疾患の有病率の増加が、市場成長を大きく後押ししています。さらに、これらの病気を治療するための個別化医薬品の開発により、個々の患者の要求に応じて診断法や治療法を変更することが可能になりました。さらに、次世代シーケンシング（NGS）の登場、ゲノムデータベースの開発、GEAの成功率の向上、遺伝子治療の研究開発（R&D）への注力強化など、さまざまな技術的進歩が市場成長をさらに促進すると予測されます。

本レポートで扱う主要質問

  • 世界の遺伝子発現解析市場の規模は？
  • 2024～2032年にかけての世界の遺伝子発現解析市場の予想成長率は？
  • 遺伝子発現解析の世界市場を牽引する主要因は何か？
  • COVID-19が世界の遺伝子発現解析市場に与えた影響は？
  • 遺伝子発現解析の世界市場における製品・サービス別の区分は？
  • 遺伝子発現解析の世界市場における技術別の区分は？
  • 遺伝子発現解析の世界市場の生産能力別の区分は？
  • 遺伝子発現解析の世界市場のエンドユーザー別の区分は？
  • 遺伝子発現解析の世界市場における主要地域は？
  • 遺伝子発現解析の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の遺伝子発現解析市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • 消耗品
  • 器具
  • サービス

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
  • 次世代シーケンサー（NGS）
  • DNAマイクロアレイ
  • サンガーシーケンス
  • その他

第8章 市場内訳：生産能力別

  • 中低プレックス遺伝子発現解析
  • 高プレックス遺伝子発現解析

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオ企業
  • 学術機関・研究センター
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
    • ペルー
    • その他
  • 中東・アフリカ
    • トルコ
    • サウジアラビア
    • イラン
    • アラブ首長国連邦
    • その他

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

  • 概要
  • インバウンド物流
  • オペレーション
  • アウトバウンドロジスティクス
  • マーケティングとセールス
  • サービス

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格指標

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies, Inc.
    • BGI Genomics Co., Ltd.
    • Bio-Rad Laboratories, Inc.
    • Eurofins GSC Lux SARL
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Illumina, Inc.
    • Oxford Gene Technology IP Limited
    • Pacific Biosciences of California Inc.
    • PerkinElmer Inc.
    • QIAGEN GmbH
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Gene Expression Analysis Market: Major Drivers and Challenges
  • Figure 2: Global: Gene Expression Analysis Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Gene Expression Analysis Market: Breakup by Products & Services (in %), 2023
  • Figure 4: Global: Gene Expression Analysis Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Gene Expression Analysis Market: Breakup by Capacity (in %), 2023
  • Figure 6: Global: Gene Expression Analysis Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Gene Expression Analysis Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Gene Expression Analysis Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Gene Expression Analysis (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Gene Expression Analysis (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Gene Expression Analysis (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Gene Expression Analysis (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Gene Expression Analysis (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Gene Expression Analysis (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Gene Expression Analysis (Polymerase Chain Reaction- PCR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Gene Expression Analysis (Polymerase Chain Reaction- PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Gene Expression Analysis (Next Generation Sequencing- NGS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Gene Expression Analysis (Next Generation Sequencing- NGS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Gene Expression Analysis (DNA Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Gene Expression Analysis (DNA Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Gene Expression Analysis (Sanger Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Gene Expression Analysis (Sanger Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Gene Expression Analysis (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Gene Expression Analysis (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Gene Expression Analysis (Low-to Mid-Plex Gene Expression Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Gene Expression Analysis (Low-to Mid-Plex Gene Expression Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Gene Expression Analysis (High-Plex Gene Expression Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Gene Expression Analysis (High-Plex Gene Expression Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Gene Expression Analysis (Pharmaceutical and Biotech Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Gene Expression Analysis (Pharmaceutical and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Gene Expression Analysis (Academic Institutes and Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Gene Expression Analysis (Academic Institutes and Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Gene Expression Analysis (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Gene Expression Analysis (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Europe: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Europe: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Germany: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Germany: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: France: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: France: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United Kingdom: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United Kingdom: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Italy: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Italy: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Spain: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Spain: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Russia: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Russia: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia Pacific: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia Pacific: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Argentina: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Argentina: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Colombia: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Colombia: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Chile: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Chile: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Peru: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Peru: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Turkey: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Turkey: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Saudi Arabia: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Saudi Arabia: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Iran: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Iran: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: United Arab Emirates: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: United Arab Emirates: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Others: Gene Expression Analysis Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Others: Gene Expression Analysis Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Global: Gene Expression Analysis Industry: SWOT Analysis
  • Figure 102: Global: Gene Expression Analysis Industry: Value Chain Analysis
  • Figure 103: Global: Gene Expression Analysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gene Expression Analysis Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Gene Expression Analysis Market Forecast: Breakup by Products & Services (in Million US$), 2024-2032
  • Table 3: Global: Gene Expression Analysis Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Gene Expression Analysis Market Forecast: Breakup by Capacity (in Million US$), 2024-2032
  • Table 5: Global: Gene Expression Analysis Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Gene Expression Analysis Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Gene Expression Analysis Market: Competitive Structure
  • Table 8: Global: Gene Expression Analysis Market: Key Players
目次
Product Code: SR112024A1832

The global gene expression analysis market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032.

Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products. They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.

The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth. Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gene expression analysis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on products & services, technology, capacity and end-user.

Breakup by Products & Services:

Consumables

Instruments

Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

DNA Microarray

Sanger Sequencing

Others

Breakup by Capacity:

Low-to Mid-Plex Gene Expression Analysis

High-Plex Gene Expression Analysis

Breakup by End-User:

Pharmaceutical and Biotech Companies

Academic Institutes and Research Centers

Others

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Others

Middle East and Africa

Turkey

Saudi Arabia

Iran

United Arab Emirates

Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Eurofins GSC Lux SARL, F. Hoffmann-La Roche Ltd, GE Healthcare, Illumina, Inc., Oxford Gene Technology IP Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN GmbH, Thermo Fisher Scientific Inc. etc.

Key Questions Answered in This Report

  • 1. How big is the global gene expression analysis market?
  • 2. What is the expected growth rate of the global gene expression analysis market during 2024-2032?
  • 3. What are the key factors driving the global gene expression analysis market?
  • 4. What has been the impact of COVID-19 on the global gene expression analysis market?
  • 5. What is the breakup of the global gene expression analysis market based on the product & services?
  • 6. What is the breakup of the global gene expression analysis market based on the technology?
  • 7. What is the breakup of the global gene expression analysis market based on the capacity?
  • 8. What is the breakup of the global gene expression analysis market based on the end-user?
  • 9. What are the key regions in the global gene expression analysis market?
  • 10. Who are the key players/companies in the global gene expression analysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gene Expression Analysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Products & Services

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Next Generation Sequencing (NGS)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Microarray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Sanger Sequencing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Capacity

  • 8.1 Low-to Mid-Plex Gene Expression Analysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 High-Plex Gene Expression Analysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Pharmaceutical and Biotech Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic Institutes and Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia-Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Argentina
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
    • 10.4.4 Colombia
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Chile
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
    • 10.4.6 Peru
      • 10.4.6.1 Market Trends
      • 10.4.6.2 Market Forecast
    • 10.4.7 Others
      • 10.4.7.1 Market Trends
      • 10.4.7.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Turkey
      • 10.5.1.1 Market Trends
      • 10.5.1.2 Market Forecast
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Market Trends
      • 10.5.2.2 Market Forecast
    • 10.5.3 Iran
      • 10.5.3.1 Market Trends
      • 10.5.3.2 Market Forecast
    • 10.5.4 United Arab Emirates
      • 10.5.4.1 Market Trends
      • 10.5.4.2 Market Forecast
    • 10.5.5 Others
      • 10.5.5.1 Market Trends
      • 10.5.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Service

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BGI Genomics Co., Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eurofins GSC Lux SARL
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GE Healthcare
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Illumina, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Gene Technology IP Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Pacific Biosciences of California Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 QIAGEN GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis